Sector pending / Biological Products, Except Diagnostic SubstancesUpdated 2026-05-10 22:07 UTC

MUN/7V0 stock hub

MUN/7V0 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

MUN/7V0is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

92.4M

Munich Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

MUN/7V0

In the news

Latest news · MUN/7V0

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E69.2

P25 n/aP50 n/aP75 n/a

Trailing P/E5

P25 n/aP50 n/aP75 n/a

ROE18.5

P25 n/aP50 n/aP75 n/a

ROIC189.8

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All MUN/7V0 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

178

Groups with data

Currency

EUR

Showing 178 of 178 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Germany
Country code	DE
Employees	176.8
Employees Change	-58.5%
Employees Change Percent	-24.86
Enterprise value	EUR 45.5M
Exchange	Munich Stock Exchange
Financial currency	EUR
First seen	2026-05-10
Industry	Biological Products, Except Diagnostic Substances
Last refreshed	2026-05-10
Market cap	EUR 92.4M
Price	EUR 7.7
Price currency	EUR
Rev Per Employee	154,539.24x
Sic	2836
Symbol	mun/7V0
Website	https://darwin-biotech.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	19.98%
EV Earnings	2.47x
EV/EBIT	1.73x
EV/EBITDA	1.56x
EV/FCF	-1.69x
EV/Sales	1.66x
FCF yield	-29.22%
Forward P/E	69.18x
P/B ratio	0.87x
P/E ratio	5.01x
P/S ratio	3.38x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	96.34%
EBITDA Margin	106.51%
Gross margin	45.31%
Gross Profit	EUR 12.4M
Net Income	EUR 18.5M
Pretax Margin	98.79%
Profit Margin	67.48%
Profit Per Employee	EUR 104,286
ROA	9.93
ROCE	22.62
ROE	18.46
ROIC	189.8

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	14.2%
Cagr3y	3.1%
Div CAGR3	-36.41%
Revenue Growth	50.55x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.16
Assets	EUR 153M
Cash	EUR 78.5M
Current Assets	EUR 87.6M
Current Liabilities	EUR 17.6M
Debt	EUR 3.2M
Debt EBITDA	EUR 0.11
Debt Equity	EUR 0.03
Debt FCF	EUR -0.12
Equity	EUR 106.2M
Interest Coverage	72.52
Liabilities	EUR 46.8M
Long Term Assets	EUR 65.4M
Long Term Liabilities	EUR 29.2M
Net Cash	EUR 75.3M
Net Cash By Market Cap	EUR 81.52
Net Debt EBITDA	EUR -2.59
Net Debt Equity	EUR -0.71
Tangible Book Value	EUR 98.7M
Tangible Book Value Per Share	EUR 8.22
WACC	6.43

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.05
Inventory Turnover	2.11
Net Working Capital	EUR -1.8M
Quick ratio	2.67
Working Capital	EUR 74.9M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Dividend Growth	0%
Dividend Growth Years	0%
Dividend per share	EUR 0.56
Dividend Years	4
Dividend Yield	7.31%
Ex Div Date	2025-06-30
Last Dividend	EUR 0.56
Payout Frequency	Annual
Payout Ratio	11.15%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	14.19%
200-day SMA	8.63
3Y total return	9.59%
50-day SMA	8.43
50-day SMA vs 200-day SMA	50under200
All Time High	12.5
All Time High Change	-38.4%
All Time High Date	2023-05-31
All Time Low	1.75
All Time Low Change	340%
All Time Low Date	2021-11-03
ATR	0.52
Beta	0.39
Beta1y	0.19
Beta2y	0.22
Ch YTD	-0.65
High	8
High52	11.8
High52 Date	2026-02-02
High52ch	-34.75%
Low	7.7
Low52	5.85
Low52 Date	2025-09-17
Low52ch	31.62%
Ma50ch	-8.65%
Price vs 200-day SMA	-10.72%
RSI	40.72
RSI Monthly	49.4
RSI Weekly	48.44
Sharpe ratio	0.35x
Sortino ratio	0.62
Total Return	7.31%
Tr YTD	-0.65
Tr1m	-13.97%
Tr1w	-14.92%
Tr3m	-0.65%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR 26.4M
Operating margin	96.34

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Net Borrowing	941,833
Shares Institutions	0.1%
Shares Out	12,000,000
Shares Qo Q	0%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR -27M
Average Volume	402.2x
Bv Per Share	8.82
CAPEX	EUR -2.1M
Ch1m	-13.97
Ch1w	-14.92
Ch1y	6.21
Ch3m	-0.65
Ch3y	-18.95
Ch6m	-3.75
Change	-3.75%
Change From Open	-3.75
Close	8
Days Gap	0
Depreciation Amortization	2,781,433
Dollar Volume	3,850
Earnings Date	2026-05-12
EBIT	EUR 26.4M
EBITDA	EUR 29.1M
EPS	EUR 1.54
F Score	2
FCF	EUR -27M
FCF EV Yield	-59.3x
FCF Per Share	EUR -2.25
Financing CF	-1,479,680
Fiscal Year End	December
Founded	2,021
Goodwill	3,712,785
Graham Number	17.47092
Graham Upside	126.9
Income Tax	EUR 8.6M
Investing CF	-2,651,771
Is Primary Listing	1
Last Report Date	2025-09-30
Last Split Date	2025-09-18
Last Split Type	Forward
Ma150	8.33
Ma150ch	-7.6%
Ma20	9.59
Ma20ch	-19.73%
Net CF	-29,396,042
Next Earnings Date	2026-05-12
Open	8
Payment Date	2025-07-02
Position In Range	0
Ppne	9,437,305
Price Date	2026-03-25
Price EBITDA	EUR 3.17
Ptbv Ratio	0.94
Relative Volume	1.24x
Revenue	27,353,446x
Tax By Revenue	31.31x
Tax Rate	31.69%
Tr6m	-3.75%
Volume	500
Z Score	3.55

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

MUN/7V0 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+7.3%

$0.56 annual per share

Payout ratio

+11.2%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

n/a

0 consecutive years of growth

Total shareholder yield

+7.3%

Next ex-dividend date: 2025-06-30

Performance

MUN/7V0 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns MUN/7V0?

Insider, institutional, and short-interest positioning.

Institutional ownership

+0.1%

Share of float held by funds and institutions

Insider ownership

n/a

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

n/a

Negative means the company is buying back shares.

Technical

MUN/7V0 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

40.7

Neutral momentum band

Price vs 200-day MA

-10.7%

50/200-day relationship not available

Beta (5Y)

0.39

Less volatile than the market

Sharpe ratio

0.35

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About MUN/7V0

Hub-level FAQ points readers to the deeper analysis pages.

What is the current mun/7V0 stock rating?

mun/7V0 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full mun/7V0 analysis?

The full report lives at /stocks/mun/7V0/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for mun/7V0?

The latest report frames mun/7V0 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the mun/7V0 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.